Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Dec 17, 2012 yancopoulos george Officer Option Execute 10,369 109.29
Feb 15, 2012 yancopoulos george Officer Disposition (Non Open Market) 67,017 109.29
Feb 14, 2012 mccorkle douglas s Officer Sell 4,562 109.01 - 110.50
Feb 14, 2012 stahl neil Officer Sell 31,202 107.83 - 113.47
Feb 15, 2012 stahl neil Officer Sell 21,082 107.79 - 108.09
Feb 16, 2012 mccorkle douglas s Officer Sell 5,353 107.50
Feb 23, 2012 shooter eric m Director Sell 20,000 103.51 - 104.05
Mar 1, 2012 brown michael s Director Automatic Sell 20,000 102.65 - 104.32
Feb 21, 2012 powchik peter Officer Automatic Sell 60,612 100.32
Feb 7, 2012 goldberg murray a Officer Automatic Sell 17,500 99.67 - 101.35
Feb 6, 2012 goldberg murray a Officer Automatic Sell 23,413 98.23
Feb 22, 2012 powchik peter Officer Automatic Sell 49,254 94.71 - 98.05
Feb 1, 2012 goldberg murray a Officer Automatic Sell 18,258 90.64 - 93.04
Feb 1, 2012 terifay robert j Officer Automatic Sell 9,439 90.54 - 91.04
Jan 31, 2012 goldberg murray a Officer Automatic Sell 25,821 90.07
Jan 31, 2012 terifay robert j Officer Automatic Sell 13,689 90.07
Jan 19, 2012 goldstein joseph l Director Automatic Sell 10,000 80.00
Jan 19, 2012 goldberg murray a Officer Automatic Sell 23,617 79.53
Jan 12, 2012 ryan arthur f Director Sell 25,500 78.86 - 79.09
Sep 21, 2011 brown michael s Director Automatic Sell 5,000 78.00
Showing 301-320 of 920 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)